Biodesix publishes data on new COVID-19 artificial intelligence-based algorithm for use in clinical decision support systems
BOULDER -- Biodesix, Inc. (Nasdaq: BDSX) today announced a publication describing the development of a new AI-based COVID-19 algorithm and important data from a related study. The paper,... Read More
Tuesday February 9, 2021 0 comments
Biodesix and HiberCell collaborate for companion diagnostic discovery, development and commercialization
BOULDER NEW YORK -- Biodesix, Inc. (Nasdaq: BDSX) today announced an agreement with HiberCell , a biotechnology company developing novel therapeutics for cancer relapse and metastasis, to further... Read More
Friday January 15, 2021 0 comments
Biodesix and Addario Lung Cancer Medical Institute initiate study to predict overall survival using checkpoint immunotherapy for lung cancer patients
BOULDER and SAN CARLOS, Calif. -- Addario Lung Cancer Medical Institute (ALCMI) and Biodesix, Inc. today announced they will begin an observational study to prospectively evaluate the clinical... Read More
Tuesday September 1, 2020 0 comments
Biodesix to provide COVID-19 testing for CSU campus
BOULDER -- Biodesix, Inc. announced it will provide COVID-19 ddPCR diagnostic testing for Colorado State University as students return to campus for the fall term, which begins Aug. 24. “The... Read More
Thursday August 13, 2020 0 comments
Biodesix appoints Franchi, Massarany to company's board of directors
BOULDER -- Biodesix, Inc. announced the appointment of Jean Franchi and Hany Massarany to the company’s board of directors. Ms. Franchi has more than 30 years of biotechnology and life... Read More
Wednesday July 22, 2020 0 comments
Biodesix pipeline test identifies patients likely to respond to immune checkpoint inhibitors
BOULDER -- Biodesix, Inc. announced publication of research findings on a diagnostic test capable of generating valuable data to help guide the treatment of patients with advanced non-small cell... Read More
Monday July 20, 2020 0 comments
Biodesix collaborates with Bio-Rad to launch test to detect COVID-19 antibodies
BOULDER -- Biodesix, Inc . announced it has collaborated with California-based Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) to launch a blood-based immunoassay-based test that identifies... Read More
Wednesday May 20, 2020 0 comments
Biodesix begins COVID-19 testing, can process 1,000 tests per day in Boulder
BOULDER -- Biodesix, Inc. announced it began SARS-CoV-2 Droplet Digital PCR (ddPCR) testing for the virus that causes COVID-19 and will immediately submit for Emergency Use Authorization from the... Read More
Wednesday April 8, 2020 0 comments
- 1
- 2
IN Sponsors
Browse
Entrepreneurial by Nature
